HC Wainwright & Co. Reiterates Buy on Imunon, Maintains $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Emily Bodnar has reiterated a 'Buy' rating on Imunon (NASDAQ:IMNN) and maintained a $12 price target.
September 15, 2023 | 3:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Imunon's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $12.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $12 indicates the firm's confidence in the stock's potential to reach this price in the short term. This could lead to increased investor confidence and potential upward movement in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100